Author: Różański J. Wójcicki J. Gawrońska-Szklarz B. Musial H.D. Millo B. Dutkiewicz G.
Publisher: Taylor & Francis Ltd
ISSN: 1060-4456
Source: Pharmacology Communications, Vol.12, Iss.3, 2002-07, pp. : 179-187
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Primary brain tumors, delta 24 and tumor metabolism
Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. :
Drug Treatment of Combined Hyperlipidemia
American Journal of Cardiovascular Drugs, Vol. 1, Iss. 5, 2001-01 ,pp. :
Emerging drugs for hyperlipidemia
By Paras Christos Hussain M Mahmood Rosenson Robert S
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
Genetically defined hyperlipidemia
By Smit Jan WA Diamant Michaela
Pharmacogenomics, Vol. 5, Iss. 3, 2004-04 ,pp. :